Den europeiske union -
norsk -
EMA (European Medicines Agency)
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
Norge -
norsk -
Statens legemiddelverk
anafranil 10 mg
pharmaand gmbh - klomipraminhydroklorid - tablett, drasjert - 10 mg
Norge -
norsk -
Statens legemiddelverk
anafranil 25 mg
pharmaand gmbh - klomipraminhydroklorid - tablett, drasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
cortiment 9 mg
ferring legemidler as - budesonid - depottablett - 9 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
Norge -
norsk -
Statens legemiddelverk
atorvastatin aristo 40 mg
aristo pharma gmbh - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg
Norge -
norsk -
Statens legemiddelverk
atorvastatin aristo 10 mg
aristo pharma gmbh - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
Norge -
norsk -
Statens legemiddelverk
atorvastatin aristo 20 mg
aristo pharma gmbh - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg
Norge -
norsk -
Statens legemiddelverk
atorvastatin aristo 80 mg
aristo pharma gmbh - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg
Norge -
norsk -
Statens legemiddelverk
entocort 3 mg
tillotts pharma gmbh - budesonid - depotkapsel, hard - 3 mg